Loading…
Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla
Rationale Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of br...
Saved in:
Published in: | Psychopharmacology 2022-01, Vol.239 (1), p.163-171 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93 |
---|---|
cites | cdi_FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93 |
container_end_page | 171 |
container_issue | 1 |
container_start_page | 163 |
container_title | Psychopharmacology |
container_volume | 239 |
creator | Godlewska, Beata R. Williams, Stephen Emir, Uzay E. Chen, Chi Sharpley, Ann L. Goncalves, Ana Jorge Andersson, Monique I. Clarke, William Angus, Brian Cowen, Philip J. |
description | Rationale
Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of brain neurochemicals relevant to aetiological processes that have been linked to CFS, for example, oxidative stress and mitochondrial dysfunction.
Methods
We studied 22 CFS patients and 13 healthy controls who underwent MRS scanning at 7 T with a voxel placed in the anterior cingulate cortex. Neurometabolite concentrations were calculated using the unsuppressed water signal as a reference.
Results
Compared to controls, CFS patients had lowered levels of glutathione, total creatine and
myo
-inositol in anterior cingulate cortex. However, when using N-acetylaspartate as a reference metabolite, only
myo
-inositol levels continued to be significantly lower in CFS participants.
Conclusions
The changes in glutathione and creatine are consistent with the presence of oxidative and energetic stress in CFS patients and are potentially remediable by nutritional intervention. A reduction in
myo
-inositol would be consistent with glial dysfunction. However, the relationship of the neurochemical abnormalities to the causation of CFS remains to be established, and the current findings require prospective replication in a larger sample. |
doi_str_mv | 10.1007/s00213-021-05986-6 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8770374</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A689970178</galeid><sourcerecordid>A689970178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEokvhD3BAlrhwSfFH_BEOSFXFl1TBpZytiTPJukrsrZ0g7b_Hy5aWIoQt2ZLnmdee8VtVLxk9Y5Tqt5lSzkRdlprK1qhaPao2rBG85lTzx9WGUiFqwaQ5qZ7lfE3LaEzztDoRjaKtFGZT3XzFNUW3xdk7mAh0IaYZJr94zMQH4rYpBu_IAIsfVyR5H_oUZ3xHgOz8FBcywxhwKUjCHAMEV6AduiXF7OJuT_Ky9nsCC9HkCvMEz6snA0wZX9zup9X3jx-uLj7Xl98-fbk4v6ydbNhSg5COmxZ6yXSDSlPeMYNoOqOlVKBd18pG4iAcBza4plMNSFViAntloBWn1fuj7m7tZuwdhiXBZHfJz5D2NoK3DyPBb-0Yf1ijNRW6KQJvbgVSvFkxL3b22eE0QcC4ZsulboVutVQFff0Xeh3XFEp5livOaGsEp_fUCBNaH4ZY7nUHUXuuTNtqyrQp1Nk_qDL7wx_FgIMv5w8S-DHBlZbnhMNdjYzag1Hs0Si2LPaXUezhxa_-7M5dym9nFEAcgVxCYcR0X9J_ZH8CHw_JiA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2621098320</pqid></control><display><type>article</type><title>Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla</title><source>SPORTDiscus</source><source>Springer Link</source><creator>Godlewska, Beata R. ; Williams, Stephen ; Emir, Uzay E. ; Chen, Chi ; Sharpley, Ann L. ; Goncalves, Ana Jorge ; Andersson, Monique I. ; Clarke, William ; Angus, Brian ; Cowen, Philip J.</creator><creatorcontrib>Godlewska, Beata R. ; Williams, Stephen ; Emir, Uzay E. ; Chen, Chi ; Sharpley, Ann L. ; Goncalves, Ana Jorge ; Andersson, Monique I. ; Clarke, William ; Angus, Brian ; Cowen, Philip J.</creatorcontrib><description>Rationale
Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of brain neurochemicals relevant to aetiological processes that have been linked to CFS, for example, oxidative stress and mitochondrial dysfunction.
Methods
We studied 22 CFS patients and 13 healthy controls who underwent MRS scanning at 7 T with a voxel placed in the anterior cingulate cortex. Neurometabolite concentrations were calculated using the unsuppressed water signal as a reference.
Results
Compared to controls, CFS patients had lowered levels of glutathione, total creatine and
myo
-inositol in anterior cingulate cortex. However, when using N-acetylaspartate as a reference metabolite, only
myo
-inositol levels continued to be significantly lower in CFS participants.
Conclusions
The changes in glutathione and creatine are consistent with the presence of oxidative and energetic stress in CFS patients and are potentially remediable by nutritional intervention. A reduction in
myo
-inositol would be consistent with glial dysfunction. However, the relationship of the neurochemical abnormalities to the causation of CFS remains to be established, and the current findings require prospective replication in a larger sample.</description><identifier>ISSN: 0033-3158</identifier><identifier>EISSN: 1432-2072</identifier><identifier>DOI: 10.1007/s00213-021-05986-6</identifier><identifier>PMID: 34609538</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Aspartic Acid ; Biomedical and Life Sciences ; Biomedicine ; Brain research ; Chronic fatigue syndrome ; Cortex (cingulate) ; Creatine ; Development and progression ; Fatigue ; Fatigue Syndrome, Chronic - diagnostic imaging ; Glutathione ; Health aspects ; Humans ; Inositol ; Magnetic Resonance Imaging ; Magnetic Resonance Spectroscopy ; Metabolites ; Mitochondria ; N-Acetylaspartate ; Neurochemistry ; Neuronal-glial interactions ; Neurosciences ; Nuclear magnetic resonance spectroscopy ; Original Investigation ; Oxidative stress ; Pharmacology/Toxicology ; Physiological aspects ; Prospective Studies ; Psychiatry ; Spectrum analysis</subject><ispartof>Psychopharmacology, 2022-01, Vol.239 (1), p.163-171</ispartof><rights>The Author(s) 2021</rights><rights>2021. The Author(s).</rights><rights>COPYRIGHT 2022 Springer</rights><rights>The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93</citedby><cites>FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34609538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Godlewska, Beata R.</creatorcontrib><creatorcontrib>Williams, Stephen</creatorcontrib><creatorcontrib>Emir, Uzay E.</creatorcontrib><creatorcontrib>Chen, Chi</creatorcontrib><creatorcontrib>Sharpley, Ann L.</creatorcontrib><creatorcontrib>Goncalves, Ana Jorge</creatorcontrib><creatorcontrib>Andersson, Monique I.</creatorcontrib><creatorcontrib>Clarke, William</creatorcontrib><creatorcontrib>Angus, Brian</creatorcontrib><creatorcontrib>Cowen, Philip J.</creatorcontrib><title>Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla</title><title>Psychopharmacology</title><addtitle>Psychopharmacology</addtitle><addtitle>Psychopharmacology (Berl)</addtitle><description>Rationale
Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of brain neurochemicals relevant to aetiological processes that have been linked to CFS, for example, oxidative stress and mitochondrial dysfunction.
Methods
We studied 22 CFS patients and 13 healthy controls who underwent MRS scanning at 7 T with a voxel placed in the anterior cingulate cortex. Neurometabolite concentrations were calculated using the unsuppressed water signal as a reference.
Results
Compared to controls, CFS patients had lowered levels of glutathione, total creatine and
myo
-inositol in anterior cingulate cortex. However, when using N-acetylaspartate as a reference metabolite, only
myo
-inositol levels continued to be significantly lower in CFS participants.
Conclusions
The changes in glutathione and creatine are consistent with the presence of oxidative and energetic stress in CFS patients and are potentially remediable by nutritional intervention. A reduction in
myo
-inositol would be consistent with glial dysfunction. However, the relationship of the neurochemical abnormalities to the causation of CFS remains to be established, and the current findings require prospective replication in a larger sample.</description><subject>Aspartic Acid</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brain research</subject><subject>Chronic fatigue syndrome</subject><subject>Cortex (cingulate)</subject><subject>Creatine</subject><subject>Development and progression</subject><subject>Fatigue</subject><subject>Fatigue Syndrome, Chronic - diagnostic imaging</subject><subject>Glutathione</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Inositol</subject><subject>Magnetic Resonance Imaging</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Metabolites</subject><subject>Mitochondria</subject><subject>N-Acetylaspartate</subject><subject>Neurochemistry</subject><subject>Neuronal-glial interactions</subject><subject>Neurosciences</subject><subject>Nuclear magnetic resonance spectroscopy</subject><subject>Original Investigation</subject><subject>Oxidative stress</subject><subject>Pharmacology/Toxicology</subject><subject>Physiological aspects</subject><subject>Prospective Studies</subject><subject>Psychiatry</subject><subject>Spectrum analysis</subject><issn>0033-3158</issn><issn>1432-2072</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kk1v1DAQhiMEokvhD3BAlrhwSfFH_BEOSFXFl1TBpZytiTPJukrsrZ0g7b_Hy5aWIoQt2ZLnmdee8VtVLxk9Y5Tqt5lSzkRdlprK1qhaPao2rBG85lTzx9WGUiFqwaQ5qZ7lfE3LaEzztDoRjaKtFGZT3XzFNUW3xdk7mAh0IaYZJr94zMQH4rYpBu_IAIsfVyR5H_oUZ3xHgOz8FBcywxhwKUjCHAMEV6AduiXF7OJuT_Ky9nsCC9HkCvMEz6snA0wZX9zup9X3jx-uLj7Xl98-fbk4v6ydbNhSg5COmxZ6yXSDSlPeMYNoOqOlVKBd18pG4iAcBza4plMNSFViAntloBWn1fuj7m7tZuwdhiXBZHfJz5D2NoK3DyPBb-0Yf1ijNRW6KQJvbgVSvFkxL3b22eE0QcC4ZsulboVutVQFff0Xeh3XFEp5livOaGsEp_fUCBNaH4ZY7nUHUXuuTNtqyrQp1Nk_qDL7wx_FgIMv5w8S-DHBlZbnhMNdjYzag1Hs0Si2LPaXUezhxa_-7M5dym9nFEAcgVxCYcR0X9J_ZH8CHw_JiA</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Godlewska, Beata R.</creator><creator>Williams, Stephen</creator><creator>Emir, Uzay E.</creator><creator>Chen, Chi</creator><creator>Sharpley, Ann L.</creator><creator>Goncalves, Ana Jorge</creator><creator>Andersson, Monique I.</creator><creator>Clarke, William</creator><creator>Angus, Brian</creator><creator>Cowen, Philip J.</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220101</creationdate><title>Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla</title><author>Godlewska, Beata R. ; Williams, Stephen ; Emir, Uzay E. ; Chen, Chi ; Sharpley, Ann L. ; Goncalves, Ana Jorge ; Andersson, Monique I. ; Clarke, William ; Angus, Brian ; Cowen, Philip J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aspartic Acid</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brain research</topic><topic>Chronic fatigue syndrome</topic><topic>Cortex (cingulate)</topic><topic>Creatine</topic><topic>Development and progression</topic><topic>Fatigue</topic><topic>Fatigue Syndrome, Chronic - diagnostic imaging</topic><topic>Glutathione</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Inositol</topic><topic>Magnetic Resonance Imaging</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Metabolites</topic><topic>Mitochondria</topic><topic>N-Acetylaspartate</topic><topic>Neurochemistry</topic><topic>Neuronal-glial interactions</topic><topic>Neurosciences</topic><topic>Nuclear magnetic resonance spectroscopy</topic><topic>Original Investigation</topic><topic>Oxidative stress</topic><topic>Pharmacology/Toxicology</topic><topic>Physiological aspects</topic><topic>Prospective Studies</topic><topic>Psychiatry</topic><topic>Spectrum analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Godlewska, Beata R.</creatorcontrib><creatorcontrib>Williams, Stephen</creatorcontrib><creatorcontrib>Emir, Uzay E.</creatorcontrib><creatorcontrib>Chen, Chi</creatorcontrib><creatorcontrib>Sharpley, Ann L.</creatorcontrib><creatorcontrib>Goncalves, Ana Jorge</creatorcontrib><creatorcontrib>Andersson, Monique I.</creatorcontrib><creatorcontrib>Clarke, William</creatorcontrib><creatorcontrib>Angus, Brian</creatorcontrib><creatorcontrib>Cowen, Philip J.</creatorcontrib><collection>SpringerOpen(OpenAccess)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Psychology Journals</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Godlewska, Beata R.</au><au>Williams, Stephen</au><au>Emir, Uzay E.</au><au>Chen, Chi</au><au>Sharpley, Ann L.</au><au>Goncalves, Ana Jorge</au><au>Andersson, Monique I.</au><au>Clarke, William</au><au>Angus, Brian</au><au>Cowen, Philip J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla</atitle><jtitle>Psychopharmacology</jtitle><stitle>Psychopharmacology</stitle><addtitle>Psychopharmacology (Berl)</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>239</volume><issue>1</issue><spage>163</spage><epage>171</epage><pages>163-171</pages><issn>0033-3158</issn><eissn>1432-2072</eissn><abstract>Rationale
Chronic fatigue syndrome (CFS) is a common and burdensome illness with a poorly understood pathophysiology, though many of the characteristic symptoms are likely to be of brain origin. The use of high-field proton magnetic resonance spectroscopy (MRS) enables the detection of a range of brain neurochemicals relevant to aetiological processes that have been linked to CFS, for example, oxidative stress and mitochondrial dysfunction.
Methods
We studied 22 CFS patients and 13 healthy controls who underwent MRS scanning at 7 T with a voxel placed in the anterior cingulate cortex. Neurometabolite concentrations were calculated using the unsuppressed water signal as a reference.
Results
Compared to controls, CFS patients had lowered levels of glutathione, total creatine and
myo
-inositol in anterior cingulate cortex. However, when using N-acetylaspartate as a reference metabolite, only
myo
-inositol levels continued to be significantly lower in CFS participants.
Conclusions
The changes in glutathione and creatine are consistent with the presence of oxidative and energetic stress in CFS patients and are potentially remediable by nutritional intervention. A reduction in
myo
-inositol would be consistent with glial dysfunction. However, the relationship of the neurochemical abnormalities to the causation of CFS remains to be established, and the current findings require prospective replication in a larger sample.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>34609538</pmid><doi>10.1007/s00213-021-05986-6</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-3158 |
ispartof | Psychopharmacology, 2022-01, Vol.239 (1), p.163-171 |
issn | 0033-3158 1432-2072 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8770374 |
source | SPORTDiscus; Springer Link |
subjects | Aspartic Acid Biomedical and Life Sciences Biomedicine Brain research Chronic fatigue syndrome Cortex (cingulate) Creatine Development and progression Fatigue Fatigue Syndrome, Chronic - diagnostic imaging Glutathione Health aspects Humans Inositol Magnetic Resonance Imaging Magnetic Resonance Spectroscopy Metabolites Mitochondria N-Acetylaspartate Neurochemistry Neuronal-glial interactions Neurosciences Nuclear magnetic resonance spectroscopy Original Investigation Oxidative stress Pharmacology/Toxicology Physiological aspects Prospective Studies Psychiatry Spectrum analysis |
title | Neurochemical abnormalities in chronic fatigue syndrome: a pilot magnetic resonance spectroscopy study at 7 Tesla |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A59%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurochemical%20abnormalities%20in%20chronic%20fatigue%20syndrome:%20a%20pilot%20magnetic%20resonance%20spectroscopy%20study%20at%207%20Tesla&rft.jtitle=Psychopharmacology&rft.au=Godlewska,%20Beata%20R.&rft.date=2022-01-01&rft.volume=239&rft.issue=1&rft.spage=163&rft.epage=171&rft.pages=163-171&rft.issn=0033-3158&rft.eissn=1432-2072&rft_id=info:doi/10.1007/s00213-021-05986-6&rft_dat=%3Cgale_pubme%3EA689970178%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c541t-a35c289ad5174e6702b18ee8b87556a7cb9545ef3c2a1fc4b64a567553ed68a93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2621098320&rft_id=info:pmid/34609538&rft_galeid=A689970178&rfr_iscdi=true |